RENX Renalytix Plc
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for clinical management of kidney diseases in Europe and the United States. It offers KidneyIntelX, a diagnostic platform that employs …
Industry Peers
Health Information Services| Headline | Source | Time |
|---|---|---|
Yesterday | ||
This week | ||
Older | ||
PPluang | ||
 Renalytix rises 7% as UBS holding grows and CEO buys shares Renalytix PLC (AIM:RENX, OTC:RNLXY, FRA:2O9)) advanced to 6p, up 7%, alongside disclosures of a larger UBS holding and share purchases by chief executive James McCullough. The kidney diagnostics company reported UBS voting rights of 6.62%, up from 5.17% in the previous notification, in a... | ||
AAskTraders | ||
 Renalytix shares surge 19% as trading resumes after cash call Shares in Renalytix PLC (AIM:RENX, OTC:RNLXY, FRA:2O9) jumped 19% to 5p on Tuesday as trading resumed following a fundraise that pulled in £10.5 million for the AIM-listed diagnostics firm. The company had paused trading in its shares at the start of September while it lined up new... | ||
 Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood-based Alzheimer’s tests accessible through Quest’s U.S. collection network. Together, these moves highlight Quest’s push to deepen its role in advanced kidney, brain health, and consumer-oriented wellness testing... | ||